MCT12 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the Monocarboxylate Transporter 12 (MCT12), also known as SLC16A12. MCT12 is a member of the solute carrier family 16, which is involved in the transport of monocarboxylates across cell membranes. These transporters play a crucial role in the cellular uptake and efflux of metabolic intermediates, such as lactate, pyruvate, and other monocarboxylates, which are essential for various metabolic pathways. By inhibiting MCT12, researchers can explore the role of this transporter in cellular metabolism and its impact on physiological processes.
In scientific research, MCT12 inhibitors serve as valuable tools for investigating the regulatory mechanisms of monocarboxylate transport and the metabolic pathways they influence. These inhibitors allow scientists to study how the inhibition of MCT12 affects cellular metabolism, energy production, and the overall metabolic flux within cells. Additionally, MCT12 inhibitors can help elucidate the transporter's role in specific tissues and organs, particularly in relation to their metabolic demands and functional activities. For instance, understanding how MCT12 contributes to metabolic processes in tissues such as the kidney, where it is highly expressed, can provide insights into the organ-specific roles of monocarboxylate transporters. Overall, the use of MCT12 inhibitors in research enhances our comprehension of metabolic regulation and the intricate network of transporters that maintain cellular homeostasis.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Lonidamine | 50264-69-2 | sc-203115 sc-203115A | 5 mg 25 mg | ¥1162.00 ¥4028.00 | 7 | |
La lonidamina inhibe directamente SLC16A, bloqueando el transporte de lactato y alterando el metabolismo celular. | ||||||
ACY-1215 | 1316214-52-4 | sc-507455 | 25 mg | ¥1241.00 | ||
El AZD3965 se une directamente al SLC16A, lo que lo convierte en un inhibidor potente y selectivo que bloquea el transporte de lactato. El AZD3965 es un inhibidor selectivo de SLC16A y MCT2, lo que dificulta el transporte de lactato y piruvato a través de la membrana plasmática. | ||||||
Bumetanide (Ro 10-6338) | 28395-03-1 | sc-200727 sc-200727A | 1 g 5 g | ¥1207.00 ¥2527.00 | 9 | |
Se ha demostrado que la bumetanida, aunque es principalmente un diurético, inhibe indirectamente el SLC16A, probablemente al afectar a procesos celulares asociados. | ||||||
Cabozantinib L-Malate Salt | 1140909-48-3 | sc-504572 | 10 mg | ¥3046.00 | ||
El AR-C155858 es un inhibidor potente y selectivo del MCT2. Inhibe el transporte de lactato bloqueando el transportador MCT2, impidiendo la captación de lactato por las células. | ||||||
Hydrazine sulfate | 10034-93-2 | sc-211599 sc-211599A | 5 g 100 g | ¥530.00 ¥756.00 | ||
Inhibe varias aminotransferasas, podría interferir con la función SLC16A por inhibición competitiva. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | ¥1038.00 ¥2358.00 | 33 | |
Inhibe la dihidrofolato reductasa, podría conducir a la acumulación de metabolitos que inhiben indirectamente SLC16A. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | ¥474.00 ¥1151.00 ¥3633.00 | 3 | |
Un agente del ciclo redox, puede modular los estados redox celulares que podrían afectar a la actividad de SLC16A. | ||||||
Phenethyl-hydrazine | 51-71-8 | sc-331686 | 500 mg | ¥4377.00 | ||
Un inhibidor no selectivo de la monoamino oxidasa, podría alterar las vías metabólicas relacionadas con el SLC16A. | ||||||
Hydroxylamine solution | 7803-49-8 | sc-250136 | 100 ml | ¥801.00 | ||
Un inhibidor general de la aminotransferasa, podría inhibir el SLC16A a través de la modificación covalente del sitio activo. | ||||||
Pyridoxal-5-phosphate | 54-47-7 | sc-205825 | 5 g | ¥1151.00 | ||
La forma activa de la vitamina B6 y un cofactor para las aminotransferasas, sus análogos pueden actuar como inhibidores de SLC16A. | ||||||